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The University of Mississippi 
 
Interoffice Memorandum 
SCHOOL OF PHARMACY 
OFFICE OF THE DEAN 
University, MS 38677 
Phone: (662) 915-7828  FAX: (662) 915-5704 
 
 
TO:  All School of Pharmacy and USDA Personnel 
 
FROM:  Charles D. Hufford, Associate Dean for Research and Graduate Programs  
 
DATE: July 26, 2010  
 
SUBJECT: Research News 
 
The following GRANTS/CONTRACTS have recently been awarded: 
1. Dr. Benjamin Banahan (P.I.-CPMM), Dr. Yi Yang (Co-P.I.-Pharmacy Administration), 
Dr. John Bentley (Co-P.I.-Pharmacy Administration), and Dr. Patrick Pace (Co-P.I.-
CPMM). Using Medicare/Medicaid Claims Data to Support Medication Outcomes and 
Pharmacovigilance Research (Department of Health and Human Services [DHHS]/Centers 
for Medicare & Medicaid Services), $500,000, June 1, 2010-May 31, 2011. 
2. Dr. Alice Clark (P.I.-Pharmacognosy), and Dr. Ameeta Agarwal (Co-P.I.-NCNPR). New 
Drugs for Opportunistic Infections-FY10-11 (National Institute of Allergy and Infectious 
Diseases [NIAID]), $388,221, July 1, 2010-June 30, 2011. 
3. Dr. Alice Clark (P.I.-Pharmacognosy), and Dr. Xing-Cong Li (Co-P.I.-NCNPR). New 
Drugs for Opportunistic Infections-Diversity Supplement-FY10-11 (NIAID), $46,910, July 
1, 2010-June 30, 2011. 
4. Dr. John Cleary (P.I.-Pharmacy Practice), and Dr. Kayla Stover (Co-P.I.-Pharmacy 
Practice). Cardiac Toxicity of Echinocandin Antifungals, $73,397, May 23, 2010-May 22, 
2012. 
5. Dr. Robert Doerksen (P.I.-Medicinal Chemistry). Rational Design of Novel Natural 
Product-Derived Cannabinoid Ligands (Center of Research Excellence in Natural Products 
Neuroscience [CORE-NPN]), $158,594, September 1, 2009-June 30, 2010. 
6. Dr. Gregory Easson (P.I.-Geology and Geological Engineering), and Dr. Marc Slattery (Co-
P.I.-Pharmacognosy). Seagrass Health Modeling and Prediction with National Aeronautics 
and Space Administration Science Data (NASA), $295,608, December 1, 2009-November 
30, 2010. 
7. Dr. Abir El-Alfy (P.I.-Pharmacology). Mechanism of Antidepressant Action of 
Cannabinoids (CORE-NPN), $161,360, September 1, 2009-June 30, 2010. 
8. Dr. Mahmoud ElSohly (P.I.-NCNPR), and Dr. Ikhlas Khan (Co-P.I.-NCNPR). Production, 
Analysis and Distribution of Cannabis, Marijuana Cigarettes and Related Materials-FY10-11 
(National Institute on Drug Abuse/National Institutes of Health [NIDA/NIH]), $500,000, 
March 16, 2010-March 15, 2011. 
9. Dr. Daneel Ferreira (P.I. - Pharmacognosy). Oligomeric/Polymeric Procynanidins: 
Development of Synthetic and Analytical Protocols (Ocean Spray Cranberries, Inc.), 
$175,000, December 1, 2009-February 28, 2012. 
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10. Dr. Deborah Gochfeld (P.I.-NCNPR). Collaborative Research: Host-Environment-Pathogen 
Interactions in a Model Coral Disease System (National Science Foundation [NSF]), 
$198,455, June 1, 2010-May 31, 2013. 
11. Dr. Mark Hamann (P.I.-Pharmacognosy). The Isolation and Characterization of 
Antimalarial Agents with Marine Micro-Organisms-Year 5 (Medicines for Malaria Venture), 
$15,000, January 1, 2006-December 31, 2011. 
12. Dr. Mark Hamann (P.I.-Pharmacognosy). Vibrio Biotechnology: Anticancer Marine 
Natural Products from GOM Bacteria (National Oceanic and Atmospheric Administration 
[NOAA]/ National Institute for Undersea Science and Technology [NIUST]), $96,172, 
October 1, 2009-September 30, 2010.  
13. Dr. Mark Hamann (P.I.-Pharmacognosy). Food Additives from Marine Bacteria (Kraft 
Foods, Inc.), $100,000, September 1, 2009-August 30, 2010. 
14. Dr. Raymond Highsmith (P.I.-NIUST), Dr. Marc Slattery (Co-P.I.-Pharmacognosy), and 
Dr. Carol Lutken (Co-P.I.-MS Mineral Resources Institute). NIUST Integrated Research and 
Technology Development: OAR Charter Fund Request (U.S. Dept. of Commerce/NOAA), 
$173,200, October 1, 2010-September 30, 2011. 
15. Dr. Melissa Jacob (P.I.-NCNPR), and Dr. Khalid Ashfaq (Co-P.I.-NCNPR). Development 
of New Agents Against Cryptococcal Infections-Year 2 (Florida Agricultural and Mechanical 
University/NIH) $12,875, June 1, 2009-May 31, 2010. 
16. Dr. Ikhlas Khan (P.I.-NCNPR), Dr. Mahmoud ElSohly (Co-P.I.-NCNPR), Dr. Troy 
Smillie (Co-P.I.-NCNPR), and Dr. Aruna Weerasooriya (Co-P.I.-NCNPR). Advancing 
Drug Development in Medicinal Plants Using Transcriptomics and Metabolics (University of 
Kentucky/NIH), $385,095, September 30, 2009-August 31, 2010. 
17. Dr. Ikhlas Khan (P.I.-NCNPR), and Dr. Troy Smillie (Co-P.I.-NCNPR). Quality 
Assessment of Botanicals-FY09-10 (Herbalife International, Inc.), $100,000, December 21, 
2009-December 20, 2010. 
18. Dr. Xing-Cong Li (P.I.-NCNPR), and Dr. Shabana Khan (Co-P.I.-NCNPR). Chemical 
Evaluation of Capsicum annum (Novus Nutrition Brands, LLC), $75,000, January 1, 2010-
March 31, 2011. 
19. Dr. Soumyajit Majumdar (P.I.-Pharmaceutics). CORE-NPN Small Grant (National Center 
for Research Resources [NCRR]), $34,104, September 1, 2009-June 30, 2010. 
20. Dr. Susan Manly (P.I.-NCNPR), and Dr. Khalid Ashfaq (Co.-P.I.-NCNPR). Production of 
Tolerance and Desensitization to Poison Ivy Urushiols (ElSohly Laboratories, Inc./NIH/ 
National Institute of Arthritis and Muculoskeletal and Skin Disease), $172,329, September 7, 
2009-August 31, 2010. 
21. Dr. Katie McClendon (P.I.-Pharmacy Practice). Assessment of Outcomes Following 
Bariatric Surgery for Mississippi State Employees (Allergan), $66,972, December 1, 2009-
June 1, 2013. 
22. Dr. Christopher McCurdy (P.I.-Medicinal Chemistry). Novel Pharmacologic Interventions 
for Drugs of Abuse-Year 4 (NIH/NIDA), $345,584, April 1, 2010-March 31, 2011. 
23. Dr. Christophe Mesangeau (P.I.-Medicinal Chemistry), and Dr. Christopher McCurdy 
(Co-P.I.-Medicinal Chemistry). Non-Peptidic Neuropeptide FF Receptor Probes (NIH), 
$176,555, July 1, 2010-June 30, 2011. 
24. Dr. Narasimha Murthy (P.I.-Pharmaceutics). Transdermal Delivery of Iron (NIH), $69,305, 
May 1, 2010-April 30, 2011.   
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25. Dr. Narasimha Murthy (P.I.-Pharmaceutics). Vehicles to Enhance Nose to Brain 
Bioavailability of Drugs (CORE-NPN), $149,771 September 1, 2009-June 30, 2010. 
26. Dr. Dale Nagle (P.I.-Pharmacognosy), and Dr. Yu-Dong Zhou (Co-P.I.-Pharmacognosy). 
Anticancer Drug Discovery that Targets Tumor Hypoxia-Year 6 (NIH/National Cancer 
Institute), $270,237, June 1, 2010-May 31, 2011. 
27. Dr. Nirmal Pugh (P.I.-NCNPR). Biological Standardization Assay Development 
(Scandinavian Clinical Nutrition), $7,756, July 1, 2010-August 31, 2010. 
28. Dr. Michael Repka (P.I.-Pharmaceutics). Bioadhesive Properties of a Generic Nail Lacquer 
in Comparison to a Branded Product (Chanelle Medical), $4,950, February 1, 2010 - 
February 28, 2010.  
29. Dr. Michael Repka (P.I.-Pharmaceutics), and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics).  Fundamental Studies in the Application of Low MW Klucel and Hot-Melt 
Extrusion for the Oral Delivery of Insoluble Drugs from Tablets, Capsules and Oral Film 
Dosage Forms-Year 1 (Hercules, Inc.), $47,440, January 1, 2010-December 31, 2010. 
30. Dr. Michael Repka (P.I.-Pharmaceutics), and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics). Center for Thermal Pharmaceutical Processing (Department of Health and 
Human Services/Health Resources and Services Administration), $611,820, September 1, 
2009-August 31, 2011. 
31. Dr. Michael Repka (P.I.-Pharmaceutics), and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics). Properties of HME Extruded Films Containing Kollidon VA-64 and New 
Polymer (BASF SE), $38,679, January 1, 2010-December 31, 2010. 
32. Dr. John Rimoldi (P.I.-Medicinal Chemistry). Synthesis of Carbon Monoxide Donors and 
Heme Oxygenase Inhibitors (University of Mississippi Medical Center/NIH/National Heart, 
Lung and Blood Institute), $26,870, September 1, 2008-July 31, 2010. 
33. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). Mississippi State Hospital and University of 
Mississippi, School of Pharmacy, Pharmacy Practice Agreement-FY10-11 (Mississippi State 
Hospital), $28,000, May 1, 2010-June 30, 2011. 
34. Dr. Ziaeddin Shariat-Madar (P.I.-Pharmacology). CORE-NPN Small Grant (NCRR), 
$35,750, September 1, 2009-June 30, 2010. 
35. Dr. Marc Slattery (P.I.-Pharmacognosy). Rapid Phase Shift to Algal Dominated Mesophotic 
Reef Communities in Response to Lionfish Invasion (University of New Hampshire/NSF) 
$28,980, December 1, 2009-November 30, 2010. 
36. Dr. Troy Smillie (P.I.-NCNPR). Analysis of Plant Samples or Dietary Supplements for the 
Presence of Hoodia gordonii-Modification 4 (Federal Trade Commission), $4,000, January 
8, 2009-June 30, 2010. 
37. Dr. Larry Walker (P.I.-NCNPR). Development of Natural Products from Plants and 
Microbes for Replacement of Synthetic Pesticides-Amendment 6 (USDA/Agricultural 
Research Service), $2,380,393, September 6, 2006-July 31, 2011.  
38. Dr. Larry Walker (P.I.-NCNPR). Bioassay Support (NIUST), $184,727, October 1, 2006-
September 30, 2011. 
39. Dr. Larry Walker (P.I.-NCNPR), and Dr. Charles Hufford (Co-P.I.-Dean’s Office). Phase 
II Construction of NCNPR Research Wing (NIH/NCRR), $13,915,445, April 1, 2010-March 
31, 2015. 
40. Dr. Larry Walker (P.I.-NCNPR), and Dr. Ikhlas Khan (Co-P.I.-NCNPR). Discovery and 
Development of Natural Product-Based Insect Management Compounds for Medical, 
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Veterinary and Urban Concern-Amendment 3 (USDA), $507,319, September 24, 2007-
September 23, 2012. 
41. Dr. Kristine Willett (P.I.-Pharmacology), and Dr. John Rimoldi (Co-P.I.-Medicinal 
Chemistry). Seagrass Proteomics: Profiling and Surveillance in the Gulf of Mexico 
(NOAA/NIUST), $100,000, October 1, 2009-September 30, 2010. 
42. Dr. Kristine Willett (P.I.-Pharmacology). BaP-mediated Reproductive and Developmental 
Toxicity (NIH/National Institute of Environmental Health Sciences), $69,305, April 13, 
2010-March 31, 2011.  
43. Dr. Kristine Willett (P.I.-Pharmacology). Distribution, Bioaccumulation and Toxicity of 
Nanosilver Particles in Medaka (Oryzias latipes)-Year 2 (U.S. Army Engineering Research 
and Development Center), $140,805, February 27, 2010-February 26, 2011. 
44. Dr. John Williamson (P.I.-Medicinal Chemistry). Fungal Endophytes as a Source for Anti-
Malarial Drug Leads (U.S. Army Medical Research Acquisition Activity), $310,055, April 
12, 2010-May 11, 2011. 
45. Dr. Yu-Dong Zhou (P.I.-Pharmacognosy), and Dr. Dale Nagle (Co-P.I.-Pharmacognosy). 
Methods to Examine Mitochondria-Targeted Marine Natural Products (NOAA/NIUST), 
$109,290, October 1, 2009-September 30, 2010. 
46. Dr. Jordan Zjawiony (P.I.-Pharmacognosy). Diterpenes as Selective Kappa Opioid 
Receptor Agents (The University of North Carolina at Chapel Hill/NIDA), $68,129, February 
15, 2010-January 31, 2011. 
47. Dr. Jordan Zjawiony (P.I.-Pharmacognosy), and Dr. Charles Burandt (Co-P.I.-NCNPR). 
Chemistry and Pharmacology of Newly Emerging Psychoactive Plants-Year 2 (NIH), 
$71,500, May 1, 2009-April 30, 2011. 
 
The following PUBLICATIONS have appeared: 
1. H. Aichaoui, F. Guenadil, C.R. McCurdy, N. Coco, D.M. Lambert, and J.H. Poupaert, 
“Synthesis and pharmacological evaluation of antioxidant chalcone derivatives of 2(3H)-
benzoxazolones”, Medicinal Chemistry Research, (2009) 467-476. 
2. Ibrahim S. Alsaadawi, and Franck E. Dayan, “Potentials and prospects of sorghum 
allelopathy in agroecosystems”, Allelopathy Journal, 24 (2009) 255-270. 
3. John Baynes and David B. Murray, “Cardiac and renal function are progressively impaired 
with aging in Zucker Diabetic Fatty type II diabetic rats”, Landes Bioscience Journals, 2010. 
4. D. Bialonska, S. Kasimsetty, K. Schrader, and D. Ferreira, “The Effect of Pomegranate 
(Punica granatum L.) By-products and Ellagitannins on the Growth of Human Gut Bacteria”, 
Journal of Agricultural and Food Chemistry, 57 (2009) 8344-8349. 
5. D. Bialonska, S.G. Kasimsetty, S.I. Khan, and D. Ferreira, “Urolithins, Intestinal Microbial 
Metabolites of Pomegranate Ellagitannins, Exhibit Potent Antioxidant Activity in a Cell 
Based Assay”, Journal of Agricultural and Food Chemistry, 57 (2009) 10181-10186. 
6. Alicia S. Bouldin, Erin Renee Holmes, Dewey D. Garner, and Ann Hein Devoe, “Purchasing 
and Managing Inventory”, Pharmacy Management, Leadership, Marketing, and Finance, 
Chapter 8, Jones and Bartlett Publishers, Copyright 2011. 
7. P. Carvalho, E.B. Furr, and C.R. McCurdy, “(E)-methyl 2-((2S,3S,12bR)-3-ethyl-8-methoxy-
1,2,3,4,6,7,12,12b-octahydroindolo [2,3-a]quinolizin-2-yl)-3-methoxyacrylate”, Acta 
Crystallographica Section E: Structure Reports Online, (2009) 1441-1442. 
8. Naseem A. Charoo, Ziyaur Rahman, Michael A. Repka, and S.N. Murthy, “Electroporation: 
An Avenue for Transdermal Drug Delivery, Current Drug Delivery, 7 (2010) 125-136. 
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9. Eva Csongradi, Trinity Vera, John M. Rimoldi, Rama S.V. Gadepalli, and David E. Stec, “In 
vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor”, 
Pharmacological Research, 61 (2010) 525-530. 
10. P.R. Daga, J. Duan, and R.J. Doerksen, “Computational model of hepatitis B virus DNA 
polymerase: Molecular dynamics and docking to understand resistant mutations”, Protein 
Science, 19 (2010) 796-807.  
11. Pankaj R. Daga, Ronak Y. Patel, and Robert J. Doerksen, “Template-based Protein 
Modeling: Recent Methodological Advances”, Current Topics in Medicinal Chemistry, 10 
(2010) 84-94.  
12. Franck E. Dayan, J’Lynn Howell, and Jeffrey D. Weidenhamer, “Dynamic root exudation of 
sorgoleone and its in planta mechanism of action”, Journal of Experimental Botany, 60 
(2009) 2107-2117. 
13. Franck E. Dayan, Maria L.B. Trindade, and Edivaldo D. Velini, “Amicarbazone, a New 
Photosystem II Inhibitor”, Weed Science, 57 (2009) 579-583. 
14. F. Dayan, N. Singh, C.R. McCurdy, C. Godfrey, L. Larsen, R. Weavers, J. Van Kink, and N. 
Perry, “b-Triketone Inhibitors of Plant p-Hydroxyphenylpyruvate Dioxygenase: Modeling 
and Comparative Molecular Field Analysis of Their Interactions”, Journal of Agricultural 
and Food Chemistry, 57 (2009) 5194-5200. 
15. F.E. Dayan, P.R. Daga, S.O. Duke, R.M. Lee, P.J. Tranel, and R.J. Doerksen, “Biochemical 
and structural consequences of a glycine deletion in the α-8 helix of protoporphyrinogen 
oxidase”, BBA - Proteins and Proteomics, 1804 (2010). 
16. Franck E. Dayan, Agnes M. Rimando, Zhiqiang Pan, Scott R. Baerson, Anne Louise 
Gimsing, and Stephen O. Duke, “Molecules of Interest – Sorgoleone”, Phytochemistry, 71 
(2010) 1032-1039. 
17. L. Dhooghe, S. Maregesi, I. Mincheva, D. Ferreira, J.P.J. Marais, F. Lemière, P. Cos, L. 
Maes, A. Vlietinck, S. Apers, and L. Pieters. “Antiplasmodial Activity of (I-3, II-3)-
Biflavonoids and Other Constituents from Ormocarpum kirkii” Phytochemistry, 71 (2010) 
785-791. 
18. Jessica A. DiGirolamo, Xing-Cong Li, Melissa R. Jacob, Alice M. Clark, and Daneel 
Ferreira, “Reversal of Fluconazole Resistance by Sulfated Sterols from the Marine Sponge 
Topsentia sp.”, Journal of Natural Products, 72 (2009) 1524-1528. 
19. Yuanqing Ding, Xing-Cong Li, and Daneel Ferreira, “4-Arylflavan-3-ols as 
Proanthocyanidin Models: Absolute Configuration via Density Functional Calculation of 
Electronic Circular Dichroism”, Journal of Natural Products, 73 (2010) 435-440. 
20. Stephen Duke, “Parasitic weeds, a scientific challenge”, Chemistry and Industry, (2009). 
21. Stephen O. Duke, Franck E. Dayan, Joanna Bajsa, Kumudini M. Meepagala, Ruth A. 
Hufbauer, and Amy C. Blair, “The case against (-)-catechin involvement in allelopathy of 
Centaurea stoebe (spotted knapweed)”, Plant Signaling & Behavior, 4 (2009) 422-424. 
22. Abir T. El-Alfy, Kelly Ivey, Keisha Robinson, Safwat Ahmed, Mohamed Radwan, Desmond 
Slade, Ikhlas Khan, Mahmoud ElSohly, and Samir Ross, “Antidepressant-like effect of ∆9-
tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.”, 
Pharmacology, Biochemistry and Behavior, 95 (2010) 434-442. 
23. Abir T. El-Alfy, Lisa Wilson, Mahmoud A. ElSohly, and Ehab A. Abourashed, “Towards a 
better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad 
assay”, Journal of Ethnopharmacology, 126 (2009) 280-286. 
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24. Xiefan Fang, Wu Dong, Cammi Thornton, and Kristine L. Willett, “Benzo[a]pyrene effects 
on glycine N-methyltransferase mRNA expression and enzyme activity in Fundulus 
heteroclitus embryos”, Aquatic Toxicology, 98 (2010) 130-138. 
25. D. Ferreira, J.P.J. Marais, C. Coleman, and D. Slade, “Proanthocyanidins: Chemistry and 
Biology”, Comprehensive Natural Products Chemistry II, Chapter 6.18 (2010) 606-662. 
26. Schwanda K. Flowers, Ross E. Vanderbush, Jan K. Hastings, and Donna West, “Web-based 
Multimedia Vignettes in Advanced Community Pharmacy Practice Experiences”, American 
Journal of Pharmaceutical Education, 74 (2010). 
27. Xiang Fu, Xing-Cong Li, Yan-Hong Wang, Bharathi Avula, Troy J. Smillie, Wilfred 
Mabusela, James Syce, Quinton Johnson, William Folk, and Ikhlas A. Khan, “Flavanol 
Glycosides from the South African Medicinal Plant Sutherlandia frutescens”, Planta Med, 76 
(2010) 178-181. 
28. A.M. Galal, D. Slade, W. Gul, A.T. El-Alfy, D. Ferreira, and M.A. ElSohly, “Naturally 
Occurring and Synthetic Cannabinoids and their Potential Therapeutic Applications”, Recent 
Patents Reviews on CNS Drug Discovery, 4 (2009) 112-136. 
29. J.D. Gardner, D.B. Murray, T.G. Voloshenyuk, G.L. Brower, J.M. Bradley, and J.S. Janicki, 
“Estrogen attenuates chronic volume overload induced structural and functional remodeling 
in male rat hearts”, Am J. Physiol Heart Circ Physiol, 298 (2009) 497-504. 
30. Archana J. Gawde, Charles L. Cantrell, and Valtcho D. Zheljazkov, “Dual extraction of 
essential oil and podophyllotoxin from Juniperus virginiana”, Industrial Crops and 
Products, 30 (2009) 276-280. 
31. J.J.C. Grove, P.S. van Heerden, D. Ferreira, and B.C.B. Bezuidenhoudt, “Conversion of 
Pravastatin Into an Advanced Intermediate for the Synthesis of the HMG-CoA Reductase 
Inhibitor BB-476”, Tetrahedron Letters, 51 (2010) 57-59. 
32. N.N. Henyan, D.M. Riche, J.J. Pitcock, and D.C. Strickland, “Marked Transaminase 
Elevations and Worsening A1C Resulting from Polyherbal Use in a Patient with Diabetes”, 
Journal of Pharmacy Practice, 22 (2009) 600-605. 
33. Erin Renee Holmes, “Pharmacists’ interventions: So many factors, so little time”, Research 
in Social and Administrative Pharmacy, 6 (2010) 3-5. 
34. Amany K. Ibrahim, Mohamed M. Radwan, Safwat A. Ahmed, Desmond Slade, Samir A. 
Ross, Mahmoud A. ElSohly, and Ikhlas A. Khan, “Microbial metabolism of cannfalavin A 
and B isolated from Cannabis sativa”, Phytochemistry, 71 (2010) 1014-1019. 
35. Mohamed A. Ibrahim, Arsala A. Mansoor, Amanda Gross, M. Khalid Ashfaq, Melissa Jacob, 
Shabana I. Khan, and Mark T. Hamann, “Methicillin-Resistant Staphylococcus aureus 
(MRSA)-Active Metabolites from Platanus occidentalis (American Sycamore), Journal of 
Natural Products, 72 (2009) 2141-2144. 
36. H. Kamel, X-C. Li, D. Ferreira, Y. Ding, M. Slattery, and F. Fronczek, “Beyond 
Polymaxenolide: Cembrane-Africanane Terpenoids from the Hybrid Soft Coral Sinularia 
maxima X S polydactyla”, Journal of Natural Products, 72 (2009) 900-905. 
37. S. G. Kasimsetty, D. Bialonska, K.R. Muntha, C. Thornton, K.L. Willet, and D. Ferreira, 
“Effects of Pomegranate Chemical Constituents/Intestinal Microbial Metabolites on CYP1B1 
in 22Rv1 Prostate Cancer Cells”, Journal of Agricultural and Food Chemistry, 57 (2009) 
10636-10644. 
38. S. Kasimsetty, D. Bialonska, G. Ma, S.I. Khan, and D. Ferreira, “Colon Cancer 
Chemopreventive Effects of Pomegranate Juice Ellagitannins and their Colonic Microfloral 
Metabolites”, Journal of Agricultural and Food Chemistry, 58 (2010) 2180-2187. 
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39. S. Kudrimoti, S.A. Ahmed, P.R. Daga, A.E. Wahba, S.I. Khalifa, R.J. Doerksen, and M.T. 
Hamann, “Semisynthetic latrunculin B analogs: Studies of actin docking support a proposed 
mechanism for latrunculin bioactivity”, Bioorganic & Medicinal Chemistry, 17 (2009) 7517-
7522. 
40. Swapnil J. Kulkarni, Yakambram Pedduri, Amar G. Chittiboyina, and Mitchell A. Avery, 
“Asymmetric Total Synthesis of the Caspase-1 Inhibitor (–)-Berkeleyamide A”, Journal of 
Organic Chemistry, 75 (2010) 3113-3116. 
41. L. Kutrzeba, D. Ferreira, and J.K. Zjawiony, “Intramolecular Transacetylation in Salvinorins 
D and E”, Journal of Natural Products, 73 (2010) 707-708.  
42. S.P. Levick, D.B. Murray, J.S. Janicki, and G.L. Brower, “Sympathetic nervous system 
modulation of inflammation and remodeling in the hypertensive heart”, Hypertension, 55 
(2010) 270-276.  
43. J. Li, Y. Ding, X-C. Li, D. Ferreira, S.I. Khan, T. Smillie, and I. A. Khan, “Scuteflorins A 
and B, Dihydropyranocoumarins from Scutellaria lateriflora”, Journal of Natural Products, 
72 (2009) 983-987. 
44. H. Liu, C.R. McCurdy, and R.J. Doerksen, “Computational study on the conformations of 
mitragynine and mitragynaline”, Journal of Molecular Structure: THEOCHEM, 945 (2010) 
57-63. 
45. Qing Liu, Ping Zhao, Xing-Cong Li, Melissa R. Jacob, Chong-Ren Yang, and Ying-Jun 
Zhang, “New a-Tetralone Galloylglucosides from the Fresh Pericarps of Juglans sigillata”, 
Helvetica Chimica Acta, 93 (2010) 265-271. 
46. Francis Machumi, Voldymyr Samoylenko, Abiy Yenesew, Solomon Derese, Jacob O. 
Midiwo, Frank T. Wiggers, Melissa R. Jacob, Babu L. Tekwani, Shabana I. Khan, Larry A. 
Walker, and Ilias Muhammad, “Antimicrobial and Antiparasitic Abietane Diterpenoids from 
the Roots of Clerodendrum eriophyllum”, Natural Product Communications, 5 (2010) 853-
858. 
47. Soumyajit Majumdar, Tushar Hingorani, and Ramesh Srirangam, “Evaluation of Active and 
Passive Transport Processes in Corneas Extracted from Preserved Rabbit Eyes”, Journal of 
Pharmaceutical Sciences, 99 (2010) 1921-1930. 
48. Shui-Chun Mao, Yang Liu, J. Brian Morgan, Mika B. Jekabsons, Yu-Dong Zhou, and Dale 
G. Nagle, “Lipophilic 2,5-Disubstituted Pyrroles from the Marine Sponge Mycale sp. Inhibit 
Mitochondrial Respiration and HIF-1 Activation”, Journal of Natural Products, 72 (2009) 
1927-1936. 
49. K.S. McClendon, D.M. Riche, and G.I. Uwaifo, “Orlistat: current status in clinical 
therapeutics”, Expert Opinion on Drug Safety, 8 (2009) 727-744. 
50. Zlatko Mehmedic, Suman Chandra, Desmond Slade, Heather Denham, Susan Foster, Amit S. 
Patel, Samir A. Ross, Ikhlas A. Khan, and Mahmoud A. ElSohly, “Potency Trends of ∆9-
THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008”, 
Journal of Forensic Sciences, (2010).  
51. Damaris A.F. Meujo, Dion A. Kevin, Jiangnan Peng, John J. Bowling, Jianping Liu, and 
Mark T. Hamann, “Reducing oyster-associated bacteria levels using supercritical fluid CO2 
as an agent of warm pasteurization”, International Journal of Food Microbiology, 138 (2010) 
63-70. 
52. Cassia S. Mizuno, Amar G. Chittiboyina, Falgun H. Shah, Akshay Patny, Theodore W. 
Kurtz, Harrihar A. Pershadsingh, Robert C. Speth, Vardan T. Karamyan, Paulo B. Carvalho, 
and Mitchell A. Avery, “Design, Synthesis, and Docking Studies of Novel Benzimidazoles 
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TECHNOLOGY TRANSFER transactions: 
(In the interest of protecting confidential information, the names and titles associated with 
School of Pharmacy invention disclosures and patent applications will no longer be published 
until after a patent has issued.) 
Research Disclosures Filed from September 2009 to Present: 3 
US Patents Pending: 25 
Recent US Patents Granted: 
Agents with Selective K-Opioid Receptor Activity 
7,687,538 
Issued: March 30, 2010 
Inventors:  Jordan Zjawiony, Hesham Fahmy, Jeremy Stewart, Brian Roth 
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The following SPECIAL ANNOUNCEMENTS are also listed: 
• Mr. Sunil Battu (Pharmaceutics) and Mr. Swapnil Kulkarni (Medicinal Chemistry) 
were honored with Graduate Achievement Awards during Commencement activities in 
May. 
• Ms. Sarah Chajkowski was presented with the Robert A. Magarian Outstanding 
Podium Presentation Award, and Mr. Swapnil Kulkarni was presented with the 
Thomas L. Lemke Outstanding Poster Presentation Award, during the 2010 MALTO 
meeting held in May.  Both are Medicinal Chemistry graduate students.  MALTO is an 
annual meeting of the Medicinal Chemistry and Pharmacognosy departments from 
Schools of Pharmacy in Mississippi, Arkansas, Louisiana, Texas and Oklahoma. 
• Dr. Ikhlas Khan was selected as the recipient of the 2010 American Herbal Products 
Association (AHPA) Herbal Insight Award.  This award is given to individuals or non-
commercial organizations that have a significant impact on furthering knowledge and 
understanding of botanicals and their uses.  Dr. Khan was also named as the recipient of 
the 2011Tyler Prize during the annual meeting of the American Society of 
Pharmacognosy.  The Tyler Prize is awarded to recognize an individual who has made 
outstanding scientific contributions to the broad field of dietary supplements, with special 
emphasis on botanicals.   
• Dr. Leigh Ann Ross was named by the American Association of Colleges of Pharmacy 
as one of three finalists for the Transformational Community Service Award.  This 
award recognizes the project that her very capable and committed team is doing in the 
Mississippi Delta to meet the needs of under served citizens.  This complex and 
innovative project is truly making a difference in the lives of families and simultaneously 
creating learning opportunities for our students and pharmacy residents. 
• Mr. Philip Schwab (Pharmacy Administration) received the APhA-APRS ESAS 
Postgraduate Best Paper Award Honorable Mention during the annual meeting of the 
American Pharmaceutical Association in March,   
 
 
Please continue to send me important research and graduate information so that I might share it 
with your faculty colleagues.   
 
 
cc: Dean Barbara G. Wells 
 Ms. Dabney Weems  
 Dr. Robin Buchannon, Office of Research 
 
 
 
